Electronic fetal monitoring (EFM) is the most commonly-used screening test in developed countries, applied to almost all deliveries in a hospital setting. 1 Although EFM aims to be a noninvasive tool to reduce adverse outcomes by identifying fetuses that are developing acidemia, its value has not been fully established. 2 The challenges of interpreting EFM patterns have been extensively discussed in the literature, with an ongoing debate on which EFM patterns are most predictive of acidemia. [2][3][4] In the hope of improving the yield of EFM patterns for the prediction of neonatal outcomes, a 2008 consensus focused on